ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500660 announcements Glaxosmith announcements and dividends declared BSE

Glaxosmith Complete list of announcements declared & dividend announcements by Glaxosmith 500660

Glaxosmith 500660 listed on BSE and deals in

Announcements and dividends declared by Glaxosmith 500660

GlaxoSmithKline to ship 600,000 more doses of COVID treatment sotrovimab to U.S.
GlaxoSmithKline and partner Vir Biotechnology said Tuesday that the U.S. government will buy 600,000 doses of sotrovimab, an investigational monoclonal antibody for early COVID-19 treatment. The extra doses will be delivered in the first quarter of 2022
Announcement as on 11 January 2022

GlaxoSmithKline, Vir increases supply of COVID-19 antibody therapy to Canada to 20,000 doses
GlaxoSmithKline PLC announced Thursday an agreement to supply the Government of Canada with 20,000 doses of Sotrovimab, the COVID-19 monoclonal antibody therapy the company developed with Vir Biotechnology Inc. . The agreement follows Canada's initial ord
Announcement as on 06 January 2022

GlaxoSmithKline says Sotrovimab antibody retains activity against omicron
GlaxoSmithKline says Sotrovimab antibody retains activity against omicron
Announcement as on 02 December 2021

Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine?
There's a big battle shaping up with several large drugmakers developing respiratory syncytial virus (RSV) vaccines. Johnson & Johnson (NYSE: JNJ) recently announced positive results from a phase 2 study of its RSV vaccine candidate. In this Motley Fool Li
Announcement as on 17 October 2021

With China lagging at this point, big opportunity for India in API, says A Vaidheesh, former MD, GlaxoSmithKline Pharmaceuticals
It is a mixed bag but API is definitely a very big element in the pharma industry which is emerging as one of the big component for growth for certain companies. There is also big support from the government for API.
Announcement as on 23 August 2021

Announcements by Glaxosmith first page | Next page | Prev page |

500660 Glaxosmith current price & indicator signals

Moving Averages for Glaxosmith

  • 5Day Average: 2290.41
  • 12Day Average: 2367.68
  • 20Day Average: 2424.49
  • 50Day Average: 2462.52
  • 100Day Average: 2484.26
  • 150Day Average: 2571.48
  • 200Day Average: 2710.98

500660 Indicators & signals

Indicator MACD (12,26,9)

2358.31, 2421.1, -42.88
Indicator MACD is in negative zone

Indicator ADX (14)

22.76, 16.58, 26.36
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 39
Indicator RSI is indicating selling pressure and stock might fall.

Recent prices of 500660 Glaxosmith are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Mon Mar 2026 2283.40 2218.00 to 2394.85 1.07% 1.84 times
27 Fri Mar 2026 2259.20 2257.10 to 2325.90 -2.69% 1.39 times
25 Wed Mar 2026 2321.60 2308.00 to 2350.10 0.59% 0.73 times
24 Tue Mar 2026 2308.00 2285.50 to 2338.65 1.23% 1.32 times
23 Mon Mar 2026 2279.85 2269.05 to 2357.40 -4.24% 0.97 times
20 Fri Mar 2026 2380.90 2365.65 to 2415.00 0.14% 2.06 times
19 Thu Mar 2026 2377.65 2372.50 to 2421.35 -2.36% 0.54 times
18 Wed Mar 2026 2435.10 2431.70 to 2470.95 0.06% 0.73 times
17 Tue Mar 2026 2433.65 2398.00 to 2439.95 1.18% 0.73 times
16 Mon Mar 2026 2405.15 2379.00 to 2432.00 -0.76% 0.53 times
13 Fri Mar 2026 2423.55 2401.00 to 2482.70 -3.22% 1 times
12 Thu Mar 2026 2504.15 2434.55 to 2517.20 0.76% 2.33 times

Videos related to: 500660 announcements Glaxosmith announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500660 announcements Glaxosmith announcements and dividends declared BSE

 

Back to top